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Fungal Rhinosinusitis (FRS) is a well known entity, but only in more recent times have the types of FRS been more fully deﬁned.
In this study, we evaluate the diagnosis of FRS in a single medical center. Cases were divided into 2 main categories, non-invasive
and invasive. Non-invasive FRS included fungus ball (FB) and allergic fungal rhinosinusitis (AFRS). Invasive FRS included acute
invasive fungal rhinosinusitis (AIFRS), chronic invasive fungal rhinosinusitis (CIFRS), and chronic invasive granulomatous fungal
rhinosinusitis (CGFRS). Fungal culture data, if available was reviewed. 400 patients with FRS were identiﬁed. 87.25% were non-
invasive (45% AFRS, 40% FB, and 2% combined AFRS and FB and 12.5% were invasive 11% AIFRS 1.2% CIFRS 0.5% CGFRS.
One patient (0.25%) had combined FB/CGFRS. Aspergillus sp. or dematiaceous species were the most common fungi isolated
in AFS while Aspergillus sp. was most common in FB and AIFRS. In our experience, most FRS is non-invasive. In our patient
population, invasive FRS is rare with AIFRS representing >90% of cases. Culture data supports that a variety of fungal agents are
responsible for FRS, but Aspergillus sp. appears to be one of the most common organisms in patients with FRS.
1.Introduction
Fungal rhinosinusitis (FRS) has been a known medical entity
for several hundred years but only in more recent times the
entity has been further deﬁned. FRS comprises a variety of
diﬀerent disease processes which vary in presentation, histo-
logic appearances, and clinical signiﬁcance. Disease is most
commonly classiﬁed as being non-invasive or invasive based
onwhetherthefungihaveinvadedintothesinonasalsubmu-
cosaltissueresultingintissuenecrosisanddestruction[1–3].
Entities which are considered non-invasive FRS include fun-
gal ball (FB (an entangled mass of fungus without signiﬁcant
surrounding sinonasal inﬂammatory reaction) and allergic
fungal rhinosinusitis (AFRS) (a complex entity characterized
by the presence of allergic mucin with histologic similarities
to those reported in Allergic Bronchopulmonary Aspergillo-
sis). Non-invasive FRS often requires surgical intervention
and/or medical therapy. Invasive disease is characterized as
either acute or chronic based on the length the time symp-
toms are present before presentation. Patients with acute
invasivedisease(AIFRS)areusuallyimmunosuppressedand,
bydeﬁnition,presentwithsymptomsoflessthanone-month
duration. This entity is characterized by the presence of
fungal forms invading into the sinonasal submucosal with
frequent angioinvasion and rapid intervention is necessary.
Patientswithchronicinvasivediseasepresentwithsymptoms2 International Journal of Otolaryngology
of greater than three month duration. Two forms of chronic
invasive disease, chronic invasive FRS (CIFRS), and chronic
granulomatous FRS (CGFRS), have been described and like
AIFRS both are also serious, often requiring surgical and
medical therapy. In the current study, we evaluate the histo-
pathologic and microbiologic classiﬁcation of a large popu-
lation of FRS patients in a large quaternary care University
Medical Center in the Northeastern United States.
2.MaterialsandMethods
The study took place at the Hospital of the University of
Pennsylvania, a 725-bed academic quaternary care center.
Following approval from the University of Pennsylvania
Institutional Review Board, the Surgical Pathology archives
were searched for patients with a diagnosis of FRS between
the years 1991 and 2008. The surgical pathology reports and
histologic slides were reviewed. The patients were classiﬁed
as non-invasive (FB; AFRS and mixed FB/AFRS), invasive
(AIFRS, CIFRS, and CGFRS), or mixed invasive/non-
invasive based on known clinical and histologic criteria
(Table 1). Results of fungal cultures, if available, were
reviewed and correlated with the histopathologic ﬁndings.
3. Results
3.1. Patient Overview. Four hundred FRS patients were
identiﬁed (Tables 2 and 3). 87.25% had non-invasive disease
including 40.25% FB, 45.0% AFRS, and 2.0% combined FB
and AFRS, and 12.5% had invasive disease, including 11.0%
AIFRS, 1.0% CIFRS, and 0.5% CGFRS. One patient had
combined non-invasive (FB) and invasive disease (CGFRS)
(0.25%). Overall the mean patient age was 50 (range 18–90)
with a male to female ratio of 1.2:1.
3.2. Noninvasive FRS
3.2.1.FungalBall. Onehundredsixty-onepatientswereclas-
siﬁed as having FB. Histologically, FB was characterized by
the presence of entangled masses of fungal forms (Figure 1)
[3, 4]. In many cases, ﬁbrinopurulent material was seen
surroundingthemassoffungiandthefungalorganismswere
identiﬁed embedded in acute inﬂammation and ﬁbrinous
exudate and only visible with histochemical stains (Grocott
silver stain) for fungal organisms. In other cases, the
fungal organisms were clearly visible on hematoxylin and
eosin stains without signiﬁcant surrounding inﬂammatory
reaction. By deﬁnition, no tissue invasion or granulomatous
reaction was identiﬁed [3, 4]. The average patient age was
55 (range 18–90), and there was a female to male ratio of
2:1. The disease was localized to one sinus in 97% of cases
with no laterality predominance and was bilateral in 3% of
cases. Seventy percent of cases involved the maxillary sinus
and 27% involved the sphenoid/ethmoid sinuses. Fifteen
patients had known sinus surgery 1 month to 14 years prior
to diagnosis and an additional 14 subjects were immunosup-
pressedeitherbyamalignancyororgantransplantation.Two
Table 1: Classiﬁcation of fungal rhinosinusitis.
Histopathologic Criteria
Non-invasive FRS
Fungus ball (FB)
An entangled mass on fungi with
Minimal surrounding inﬂammatory
reaction or surrounding ﬁbrinous
necrotic exudate containing fungal forms;
no tissue invasion or granulomatous
reaction is present
Allergic fungal
rhinosinusitis (AFRS)
The presence of eosinophilic mucin
(mucinous material admixed with
eosinophils, acute inﬂammatory cells,
eosinophilic debris, and Charcot-Leyden
crystals; sparse fungi or positive fungal
cultures; no tissue invasion present)
Mixed FB/AFRS The presence of features of both AFRS
and FB
Invasive FRS
Acute (AIFRS)
Invasion of fungal forms into submucosal
with frequent angioinvasion and necrosis
in a patient with symptoms of less than
one-month duration
Chronic (CIFRS)
Invasion of fungal forms into submucosal
often with surrounding chronic
inﬂammation and ﬁbrosis in patient with
long-standing symptoms (>3-month
duration)
Chronic
granulomatous
(CGFRS)
Invasion of fungal forms into submucosal
often with surrounding chronic
inﬂammation, ﬁbrosis, and granuloma
production in patient with long-standing
symptoms (>3-month duration)
Mixed Non-invasive/
invasive FRS
A mixture of either of the invasive and
non-invasive categories
patientsshowedrecurrenceofanFB,oneat6monthsandthe
other at 7 years following the initial surgery.
One hundred seven patients had fungal culture results
available for review (Table 4). Fifty-one percent had positive
fungal cultures with Aspergillus sp. being the most common
isolate. The remaining culture positive cases grew dema-
tiaceous species as well as a variety of other fungi. Seven
patients grew multiple fungal isolates in culture with 5 of
7 showing dematiaceous species in combination with other
fungal organisms (Table 4).
3.2.2. Allergic Fungal Rhinosinusitis (AFRS). AFRS was di-
agnosed in 180 patients. The diagnosis of AFRS was estab-
lished using pathologic criteria by either the presence of
eosinophilic mucin (EM) containing fungal forms on histo-
logic examination using a Grocott silver stain or the presence
of EM without histologic evidence of fungi but with positive
fungal cultures [5–7]. Histologically, EM was characterized
by the presence of lamellated mucinous material with the
presence of eosinophils, eosinophilic debris, and Charcot-
Leyden crystals (Figure 2). In order to identify all potential
cases of AFRS, all sinus contents specimens with histologi-
cally evident EM were reviewed. Three-hundred ﬁfty-threeInternational Journal of Otolaryngology 3
Table 2: Classiﬁcation of FRS in 400 patients.
Classiﬁcation Diagnosis No. of
patients
Total no.
of patients Percentage
Non-invasive 349 87.25%
AFS 180 45.0%
FB 161 40.25%
Combined AFRS/FB 8 2.0%
Invasive 50 12.5%
Acute 44 11.0%
Chronic 4 1.0%
Chronic granulomatous 2 0.5%
Non-invasive/
invasive 1
Combined FB/chronic
granulomatous 1 0.25%
Table 3: Clinical summary of FRS patients.
Diagnosis Avg. age (range) M:F No. No. with cultures (% positive) Most common isolates (%)
FB 55 (18–90) 1:2 161 107 (51%) Aspergillus sp. (66%)
AFRS 45 (18–88) 1.2:1 180 142 (89%) Dematiaceous fungi (36%)
Aspergillus sp. (35%)
AIFRS 54 (24–82) 1.5:1 44 27 (67%) Aspergillus sp.
Rhizopus sp.
CIFRS 48 (21–65) 1:1 4 2 (100%) C. albicans
Scedosporium apiospermium
CGFRS 58 (50–66) 1:1 2 1 (100%) A. ﬂavus
Figure 1: High power of fungus ball showing entangled masses of
fungal organisms (original magniﬁcation ×200).
patients with EM were identiﬁed, 134 of which had fungal
forms by histology. Of the 219 patients without histologic
fungus, 46 had positive fungal cultures for an overall total
of 180 presumed AFRS patients. The remaining 173 patients
with EM either had negative fungal cultures (100 patients)
or unknown culture results (73 patients) and these patients
wereconsideredtohaveinsuﬃcientevidenceforapathologic
diagnosis of AFRS although since more sensitive techniques
for fungal detection such as PCR were not performed on this
population, they may still actually have AFRS.
The average patient age was 45 (range 18–88) and there
was a female-to-male ratio of 1.2:1. Thirty percent of
patients presented up to 10 years prior to AFRS diagnosis
with specimens showing chronic sinusitis with eosinophilia
and/or the presence of EM without fungal organisms. Fungal
culture results were available in 142 patients, 79% of which
were positive (Table 5). Sixty-ﬁve percent of the culture-
positive patients grew a single fungal isolate while 35% grew
more than one fungal organism. The most common single
fungal isolates were Aspergillus sp. (34%) with A. fumigatus,
A. ﬂavus, and A. niger most frequent and dematiaceous
species (30%) with Alternaria sp., Bipolaris sp., and Curvu-
laria sp. isolated most often. Specimens from the remaining
36% of patients grew a variety of other fungi including
Paecilomyces sp., Fusarium sp., Scedosporium sp., C. albicans,
and Penicillium sp. Of the patients whose cultures revealed
multiple fungal isolates, 34% grew a single dematiaceous
species combined with a nonAspergillus sp., 23% grew a
single dematiaceous species combined with Aspergillus sp.
with or without another fungal species, 16% grew multiple
Aspergillus sp. with or without a non-dematiaceous species,
14% grew multiple dematiaceous species with or without
Aspergillus sp. and 13% grew neither Aspergillus sp.n o r4 International Journal of Otolaryngology
Table 4: Fungal Cultures in 161 Patients with FB.
Single fungal
isolate (95.8%) Culture result Overall %
Aspergillus sp. 65.8%
A. fumigates 44.8%
A. ﬂavus 14.0%
Aspergillus, not ﬂavus or fumigatus 7.0%
Dematiaceous sp. 9%
Alternaria sp. 5.0%
Bipolaris sp. 2.0%
Trichophyton sp. 2.0%
Other 21%
Paecilomyces sp. 5.0%
Candida albicans 2.0%
Mucor sp. 2.0%
Nonsporulating mold 2.0%
Scedosporium sp. 5.0%
Penicillium sp. 5.0%
Multiple Fungal
Isolates (4.2%)
A. ﬂavus/A. niger/Mucor sp. 0.6%
Alternaria/Penicillium 1.2%
Alternaria/Cladosporium/Penicillium/Trichoderma 0.6%
Paecilomyces/Fusarium/Curvularia/Alternaria 0.6%
A. ﬂavus/A. NOS 0.6%
C. ciﬀerinii/C. tropicalis 0.6%
dematiaceous fungi. Forty-eight percent of patients with
multiple isolates grew them at diﬀerent points in time. One
patient grew nine diﬀerent fungal types in multiple spec-
imens cultured over a three year time period.
There were noticeable diﬀerences between the fungi
isolated in patients with EM containing fungal forms histo-
logically and those patients with EM without histologically
identiﬁable fungi but positive fungal cultures (Tables 6
and 7). In those AFRS cases with histologic fungi and
positive fungal cultures, 84% had a single fungal isolate
(35% Aspergillus sp., 36% dematiaceous species, and 13%
other including Fusarium sp. and Scedosporium sp.); however
fungal cultures in AFRS patients with positive cultures and
EM without fungal forms showed a single isolate in only
63% of cases (24% Aspergillus sp, 10% dematiaceous species,
66% non-Aspergillus/non-dematiaceous species including C.
albicans, Penicillium sp, and yeast not further speciﬁed).
3.2.3. Mixed AFRS/FB. Eight patients had a mixture of FB
and AFRS by histology. Six of these patients had evidence
of entangled masses of fungus with extensive surrounding
EM. Cultures were positive in four of these patients (A. niger,
A. ﬂavus, Alternaria sp.a n dPaecilomyces sp.) and were not
performed in the other two patients. An additional, patient
hadaninitialdiagnosisofAFRSwithnegativefungalcultures
with multiple subsequent surgeries showing EM but no
fungal forms and cultures that were either negative or
positive for A l t e r n a r i as p ,A .ﬂ a v u sand A. niger. She then
developed a FB 15 years subsequent to the initial surgery
with fungal cultures positive for A. ﬂavus. Similarly another
patient had a diagnosis of AFRS with negative cultures and
developed a FB culture positive for A. niger three years
following the initial diagnosis of AFRS.
3.3. Invasive FRS
3.3.1. Chronic Invasive FRS. There were six patients with
chronic invasive disease, two CGFRS and four CIFRS. One
of the CGFRS patients was a 50-year-old Sudanese female
with an over 20-year history of CGFRS whose cultures
grew A. ﬂavus. The other CGFRS patient was a 66-year-
old male with a long-standing history of non-insulin-
dependent diabetes mellitus who presented with symptoms
attributable to chronic rhinosinusitis. Cultures were not
performed in this patient. Histologically, both specimens
showed ﬁbrosis, granulomatous inﬂammation, and chronic
inﬂammation composed of lymphocytes and plasma cell
without signiﬁcant eosinophils (Figure 3).
TheCIFRSpatientpopulationconsistedoftwomalesand
two females. Two patients (ages 21 and 41) presented with
long-standing nasal septal perforation of unknown etiology.
Both of these patients showed mucosal ulceration with
evidence of acute and chronic inﬂammation, ﬁbrosis and
submucosal invasive fungal forms without angioinvasion.International Journal of Otolaryngology 5
Table 5: Fungal isolates in 127 AFRS patients.
Overall %
Single Fungal Isolate 65%
Aspergillus sp. 34%
A. fumigatus 41%
A. ﬂavus 25%
A. niger 22%
A. terreus 3%
A. NOS 9%
Dematiaceous sp. 30%
Alternaria sp. 35%
Bipolaris sp. 22%
Cladosporium sp. 4%
Curvularia sp. 35%
Scopulariopsis sp. 4%
Paecilomyces sp. 5%
Fusarium sp. 6%
Scedosporium sp.5 %
C. Albicans 5%
Penicillium sp. 5%
Yeast, NOS 6%
Mucor sp. 2%
Mold, NOS 2%
Multiple fungal isolates 35%
Dematiaceous species/non-Aspergillus
sp. 34%
Aspergillus sp./dematiaceous species ±
other species 23%
Multiple Aspergillus sp./± other
non-dematiaceous species 16%
Multiple dematiaceous sp. ± other
non-Aspergillus sp. 14%
Non dematiaceous sp./non-Aspergillus
sp. 13%
Cultures grew C. albicans in one patient and were not
performed in the other. The remaining two patients (ages
63 and 65) presented with a history of presumed chronic
rhinosinusitis and no known risk factors for fungal sinusitis.
Both of these patients showed chronic inﬂammation and
associated mucosal ulceration with submucosal invasive
fungal forms without angioinvasion (Figure 4). One patient
grew S. apiospermium a n dc u l t u r e sw e r en o tp e r f o r m e di n
the other.
3.3.2. Mixed FB/CGFRS. One patient showed evidence of
a FB with areas of underlying tissue invasion of fungal
forms with the presence of granulomatous inﬂammation.
This patient was a 72-year-old male who presented with
long-standing diplopia, proptosis, and a left orbital “mass.”
Histologically, the specimen consisted of a matted mass of
fungal forms consistent with FB which was associated with
the presence chronic inﬂammation with areas of submucosal
(a)
(b)
Figure 2:(a)HistologicappearancesofEMwithlamellatedappear-
ance of mucin admixed with eosinophils and eosinophilic debris
(originalmagniﬁcation ×200).(b)RarefungalformspresentinEM
in patient with AFRS which grew Aspergillus sp. in culture (original
magniﬁcation ×200).
Table 6: Fungal culture Results in 81 AFRS patients with EM and
fungi seen microscopically.
Overall %
Single isolate 84%
Aspergillus sp. 35%
Dematiaceous species 36%
Other single isolate 13%
Fusarium sp. 6%
Scedosporium sp. 3%
Mucor sp. 1%
Multiple isolates 16%
Dematiaceous species/Aspergillus sp.±
other isolate
8%
Dematiaceous species/non-Aspergillus
sp.
7%
Aspergillus sp./non-dematiaceous species 1%
ﬁbrosisandfocallygranulomatousinﬂammationwithfungal
formsinvadingintothesubmucosaltissuewithouthistologic
evidence of angioinvasion. Cultures in this patient grew A.
fumigatus.6 International Journal of Otolaryngology
Table 7: Fungal Culture Growth in 46 Patients With EM Without
Fungal Organisms but with Positive Cultures.
Overall %
Single isolate 63%
Aspergillus sp. 24%
Dematiaceous species 10%
Non-Aspergillus/non-dematiaceous
fungi 66%
C. albicans 17%
Yeast, not C. albicans 14%
Penicillium sp. 17%
Fusarium sp.3 %
Paecilomyces sp.3 %
Scedosporium apiospermium 3%
Mold not further speciﬁed 10%
Multiple isolates 37%
Multiple dematiaceous species 12%
Dematiaceous species/Aspergillus sp. ±
other isolate
17%
Dematiaceous species/non-Aspergillus
sp.
41%
Aspergillus sp./non-Dematiaceous
species
12%
Non-dematiaceous
species/non-Aspergillus sp.
17%
3.3.3. Acute Invasive FRS. Forty-four patients were classiﬁed
as having AIFRS. Eighty-four percent had a hematologic
disorder with or without bone marrow transplantation due
most commonly to acute leukemia (32 patients), non-
Hodgkin lymphoma (3 patients), and multiple myeloma (2
patients). The remaining seven patients had either treatment
or conditions that led to immunosuppression including
solid organ transplantation (2 liver and 1 kidney), systemic
necrotizing vasculitis (1 patient), ulcerative colitis (1 patient)
and non-insulin-dependent diabetes mellitus (2 patients).
Patient ages ranged from 24 and 82 with a male-to-female
ratio of 1.5:1. Fungal culture results were available in 27
patients with the most common cultured organism being
Aspergillus sp. followed by Rhizopus sp. (Table 8). Other fungi
isolatedincludedonecaseeachofAlternaria sp.,Paecilomyces
sp., and Fusarium sp. One-third of the patients had negative
fungal cultures. Histologically all patients showed necrotic
sinonasal mucosa with the presence of angioinvasive fungal
forms (Figure 5).
4. Discussion
The diversity of FRS is highlighted by its many clinical and
histopathologic presentations. Clinically, FRS can be acute
(aggressive) and chronic (indolent) [1–3]. The pathologic
spectrum encompasses a variety of diﬀerent entities which
are classiﬁed as either invasive or non-invasive and then into
(a)
(b)
Figure 3:CGFSwithgranulomatousinﬂammation(a)andGrocott
silver stain showing fungal organisms (b) (original magniﬁcation
×400 for (a) and ×400 for 3b).
speciﬁcpathologiccategorieswhicharedescriptiveofclinical
and histologic disease processes. In the current study, we
present a cohort of 400 patients with FRS observed in a
large quaternary care medical center that receives numerous
referralsforsurgicaltreatmentofrhinosinusitis,inparticular
those with symptoms of chronic rhinosinusitis. As such, the
majority of the patients that we observed were those with
non-invasive disease with an almost equal distribution of
AFRS and FB with incidences of 45% and 40%, respectively.
In our experience, invasive FRS was rare with acute disease
representing almost 90% of those with invasive disease.
Chronic invasive disease was only rarely noted in our
population and most likely reﬂects the referral population
to our medical center. Relatively similar distributions have
been seen in other studies performed in the United States.
I nas t u d yf r o mH o u s t o n ,T X ,G r a n v i l l ee ta l .r e p o r t e dn o n -
invasive disease in >90% of patients with 72% AFRS, 23%
FB, and 2.1% each of AIFRS and CGFRS [8]. In addition,
Taxy observed non-invasive disease in over 80% of FRS
patients in the Chicago area with an equal incidence of AFRS
and FB and an 8% incidence of AIFRS [9]. Overallit appears,
at least in these studies, that non-invasive FRS predominates
in the United States population. However, studies performed
in other countries such as India show signiﬁcantly fewer
FB cases and more CGFRS cases compared to these other
studies. Das et al. observed non-invasive FRS in 60% of 284
patients (AFRS 56%; FB 4%) and invasive FRS in 36% ofInternational Journal of Otolaryngology 7
(a)
(b)
Figure 4: CIFS in showing chronic inﬂammation and ﬁbrosis of
the sinonasal mucosa (a) and fungal forms without angioinvasion
invading into the sinonasal tissue on Grocott silver stain. (original
magniﬁcation ×200).
Figure 5: Fungal organisms invading into a large artery in a patient
with AIFRS. Culture grew Rhizopus sp. (original magniﬁcation
×400).
patients (AIFRS 17%, CIFRS 1%, and CGFRS 17%). [10].
Michael et al. observed a prevalence of 63% AFRS and
24% AIFRS similar to Das et al.. However, the incidence
of CIFRS was higher (10%) and CGFRS signiﬁcantly lower
(<1%) than seen in Das et al.’ study [11]. On the other
hand, while Panda et al. observed a 60% incidence of non-
invasive disease, they most commonly encountered FB in
theirseriesof178patients[12].Challaetal.observedamuch
lower incidence of non-invasive FRS (25%) versus invasive
disease (75%) with a 30% incidence of CGFRS [13]. This
Table 8: Positive culture results in 18 AIFS patients.
Overall %
Aspergillus sp. 49%
A. Fumigatus 56%
A. ﬂavus 33%
Aspergillus, NOS 11%
Rhizopus sp. 33%
Fusarium sp. 6%
Paecilomyces sp. 6%
Alternaria sp. 6%
geographic diversity may be due to diﬀerent climates and
environmental factors, as well as diﬀerent means of fungal
exposure and variation in FRS terminology and deﬁnitions;
however, the reasons for variations in FRS presentations are
not understood.
Forty percent of the FRS patients observed in our study
had FB. Panda et al. and Dufour et al. noted that FB was the
most common form of FRS in their patients in India and
France respectively, although several other studies as noted
abovehaveobservedthisformofFRStobetheleastcommon
[8–14]. The patient population we observed shared many
features to those described in Dufour et al. with an increased
incidence in elderly females, location in the maxillary sinus
and the predominance of A. fumigatus on fungal cultures.
However, our incidence of positive fungal culture was higher
(51% versus 30%) than seen in their study and, in our
patient population, we had only rare cases associated with
Scedosporium sp.
AFRS was seen in 45% of patients in this study. We
utilized basic pathologic criteria in categorizing AFRS
patients [5–7]. AFRS was diagnosed as either the presence
of EM containing fungal forms on histology (despite culture
results) or the presence of EM without histologic fungi but
positive fungal cultures. This latter group is probably the
most problematic in the current study since it is diﬃcult to
ascertain without other clinical criteria that these patients
should be truly considered as having AFRS. The diagnosis
in this group was based on the presence of EM with
positive fungal cultures; however, fungal cultures in this
patient group commonly grew neither Aspergillus sp. nor
dematiaceousfungi,twoofthemostcommonagentsisolated
in patients with AFRS, indicating that the fungi isolated may
be unrelated to the EM and could be potential contaminants.
It is possible that some of the patients with EM without
fungi but positive cultures are not truly AFRS patients and
that a positive fungal culture alone is not suﬃcient to make a
diagnosis of AFRS without other clinical ﬁndings. The other
problematic aspect of this study is that patients with EM
but with no fungi on histology and negative fungal cultures
were excluded. More sensitive fungal cultures, PCR, or
other molecular techniques may have identiﬁed fungi in this
patient group but, based on the current material available,
a classiﬁcation of these patients as having AFRS was not
possible. Since this was a retrospective study, there was no8 International Journal of Otolaryngology
way to control whether the EM material was preserved in a
fashion to allow for more sensitive culturing techniques.
There has been recent controversy over the role of fungi
in the development of chronic rhinosinusitis, an entity often
treated with antibiotic therapy. In a study by Ponikau et
al. using a sensitive fungal culturing technique, positive
fungal cultures were seen in almost 100% of chronic sinusitis
patients (although control subjects also had positive fungal
cultures) [15]. While the ﬁnding of positive fungal cultures
in most patients with chronic sinusitis is controversial in
nature and not universally accepted, there is belief that
chronic sinusitis may be related to inﬂammatory reaction to
fungi [16–18]. Of note, almost 30% of the AFRS patients
in this study initially presented with chronic sinusitis with
eosinophils but no histologic evidence of fungus.
Fungi isolated in FRS, while showing geographic varia-
tion, are often similar in the particular forms of this disease.
Aspergillus sp. particularly A. fumigatus and A. ﬂavus appears
to consistently be the most common agents isolated in
patients with FB in a variety of diﬀerent geographic locations
including our current study [10–14]. Other fungal isolates
including Scedosporium sp., Fusarium sp., and dematiaceous
fungi have also been rarely associated with this entity.
A. fumigatus, A. ﬂavus,a n dRhizopus sp. are uniformly seen
in patients with acute invasive disease worldwide [10–13].
Other rare fungi such as Fusarium sp. and dematiaceous
species may also be isolated in AIFRS. Chronic invasive
disease either CIFRS or CGFRS are also usually associated
with Aspergillus sp, particularly A. ﬂavus [10–13]. AFRS has
the most variation in fungi isolated in diﬀerent geographic
locations. Most commonly, Aspergillus sp.a n dd e m a t i a c e o u s
species are isolated but the species of fungi vary signiﬁcantly
from study to study. In studies performed in India as well
as Saudi Arabia, A. ﬂavus appears to be the most common
fungal organism cultured in AFRS [10–13, 19]. In the United
States, particularly in the South and Southwest, the majority
o fc a s e so fA F R Sg r o wd e m a t i a c e o u sf u n g ii nc u l t u r e .I n
Granville et al.’s study, almost 70% of AFRS cases grew
dematiaceous fungi and their group showed no cases with
Aspergillus sp. by culture [8]. Schubert and Goetz observed
that >80% AFRS cases were associated with dematiaceous
fungi with almost 70% due to Bipolaris sp. and only 9%
due to Aspergillus sp. [20]. Manning and Holman reported
dematiaceous fungi in almost 90% of their cases [21].
Alternatively, in the Chicago area, Taxy reported an equal
incidence of Alternaria sp. and Aspergillus sp. in their patients
withAFRS[9].Inthecurrentstudy,bothdematiaceousfungi
and Aspergillus sp. were seen at relatively similar rates with
Alternaria sp., Bipolaris sp., Curvularia sp., A. fumigatus, A.
ﬂavus, and A. niger being the most common single isolates
in patients with histologically conﬁrmed EM with fungal
organisms. We also observed several patients with multiple
diﬀerent fungal isolates either at one time or multiple times
during the disease process,. In 16% of patients with EM
and histologic fungal forms, more than one fungal isolate
was identiﬁed either at a single or at multiple time points,
most commonly Aspergillus sp.o rd e m a t i a c e o u ss p e c i e sw i t h
another fungus. This indicates that some patients may be
predisposed to develop a reaction to more than one type
of fungus including both dematiaceous and Aspergillus sp.
This study did not control for the fact that the Aspergillus
sp. may grow faster in culture than other organisms and
that, even though Aspergillus sp. may have grown as an
isolate in many AFRS patients, other types of fungi may also
be present. Interestingly, in more recent studies, using in
situ hybridization and immunohistochemistry, we have con-
ﬁrmedthepresenceofAspergillus sp. inAspergillus sp.cultur e
conﬁrmed allergic mucin containing fungal organisms (data
not shown).
Mixed types of fungal sinusitis while uncommon can
occur. In our study, 2% of patients showed a combination
of FB and AFRS. In fact, two patients originally presented
with AFRS and on subsequent surgery up to 9 years later
developed a fungal ball. The other patients had classic EM
with fungal organisms as well as an entangled mass of fungi
consistent with FB. In addition, one patient in this study had
combined FB and CGFS. About 4% of patients presented by
Das et al. had combined FRS with either AFRS, FB, or AIFRS
combined with CGFS [10]. Manning and Holman in a study
from the Southwestern United States observed combined
AFRS and CGFS in 1.5% of their patient population [21].
5. Conclusion
In summary, in this retrospective study, we present 400
patients with FRS. Non-invasive FRS was more frequently
encountered in our patient population. Invasive disease,
while less common in our group, was more commonly acute
in nature. While a variety of fungi are isolated in patients
with FRS, Aspergillus sp. still appears to be a common isolate
in our patient population.
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